Litigation

Recent Posts

High Court Upholds 3rd Circuit's Ruling, Finds Stockholder's Suit Against Merck Was Timely
Posted on 27 Apr 2010 by Michael Lefkowitz

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on April 27 affirmed a Third Circuit U.S. Court of Appeals ruling that a shareholder derivative lawsuit over Merck & Co. Inc.'s marketing of Vioxx was timely and held that the statute of... Read More

Vaccine Design Defect, Warning Claims By Parents Are Preempted, 9th Circuit Says
Posted on 27 Sep 2012 by LexisNexis Litigation Resource Community Staff

SAN FRANCISCO - (Mealey's) The Ninth Circuit U.S. Court of Appeals on Sept. 25 said design defect and failure-to-warn claims filed by the parents of a child who died after getting vaccinated are preempted by the federal vaccine law, but noted that... Read More

Merck Settles All NuvaRing Birth Control Injury Cases For $100 Million
Posted on 7 Feb 2014 by Tom Moylan

HACKENSACK, N.J. — (Mealey’s) Merck & Co. subsidiary Organon has agreed to a $100 million nationwide settlement of all claims alleging blood clot injuries from the NuvaRing contraceptive device, according to a master settlement agreement... Read More

Merck To Settle Suits Alleging Jaw Damage From Osteoporosis Drug
Posted on 10 Dec 2013 by Michael Lefkowitz

WHITEHOUSE STATION, N.J. — (Mealey's) Merck & Co. Inc. has agreed to pay $27.7 million to resolve product liability suits alleging that its osteoporosis drug Fosamax caused osteonecrosis of the jaw (ONJ), or bone death, according to a press... Read More

Supreme Court Says Vioxx Lawsuit Can Proceed
Posted on 27 Apr 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. – (AP) The Supreme Court said Tuesday investors who lost millions betting on the blockbuster drug Vioxx can sue Merck & Co. over whether the pharmaceutical giant provided enough information about the painkiller's risks before... Read More

Oil Spill Legal Mess Likely One Of Costliest Ever
Posted on 27 Jul 2010 by LexisNexis Litigation Resource Community Staff

MIAMI - (AP) BP PLC and the other companies involved in the Gulf of Mexico oil spill are faced with fast-multiplying lawsuits that will provoke one of the most drawn-out and costliest legal battles in U.S. history, one that could easily consume the $20... Read More

Australian Court: Vioxx Doubled Heart Attack Risk
Posted on 8 Mar 2010 by LexisNexis Litigation Resource Community Staff

SYDNEY, Australia – (AP) The once-popular painkiller Vioxx doubled the risk of heart attack and was unfit for consumption, an Australian court ruled Friday, awarding a man leading a class action suit against the drug's maker 287,000 Australian... Read More